thBOULDER, Colo., Jan. 6, 2026 /PRNewswire/ -- Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today announced that Kevin Koch, Ph.D., President and Chief Executive Officer, will present at the 44 Annual J.P. Morgan Healthcare Conference. Event Details: Date: Tuesday, January 13, 2026 Time: 8:15 am PT (11:15 am ET) The presentation will be webcast live; a link for the webcast can be found on the Edgewise Events & Presentations page and will be accessible for ...